(Q38868936)

English

Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda

scientific article published on 24 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

anti-retroviral agent

0 references

Kaposi's sarcoma

1 reference

based on heuristic

inferred from title

author name string

Fm Asiimwe

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dm Moore

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

W Were

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

R Nakityo

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

J Campbell

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

A Barasa

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

J Mermin

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

F Kaharuza

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

24 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

166-171

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Epidemiology of AIDS-related tumours in developed and developing countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

AIDS-related cancers in Africa: maturation of the epidemic in Uganda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Differential Impact of Combination Antiretroviral Therapy in Preventing Kaposi's Sarcoma With and Without Visceral Involvement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Virologic and Immunologic Parameters that Predict Clinical Response of AIDS-Associated Kaposi's Sarcoma to Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00955.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2011.00955.X

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38868936&oldid=2144317650"